Arbutus Biopharma Corporation (ABUS)

Oncology Corporate Profile

Stock Performance

3.5707
-0.0293

HQ Location

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia, Canada V5J 5J8

Company Description

Arbutus Biopharma Corporation is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic HBV infection. Arbutus is headquartered in Vancouver, BC, and has facilities in Doylestown, PA.

Website: http://www.arbutusbio.com/

This company does not have any commercial products

This company does not have any pipeline products

Source: http://www.arbutusbio.com/

Recent News Headlines

8/18/2017 06:17 am

8/18/2017 06:17 am

8/18/2017 06:17 am

8/14/2017 06:17 am

8/14/2017 06:17 am

8/14/2017 06:17 am

8/9/2017 06:17 pm

8/9/2017 06:17 pm

8/9/2017 06:17 pm

8/3/2017 12:17 pm

8/3/2017 12:17 pm

8/3/2017 12:17 pm

7/27/2017 12:17 am

7/12/2017 06:17 am

7/12/2017 06:17 am

6/21/2017 12:17 pm

6/19/2017 06:17 am

6/2/2017 06:17 am

6/2/2017 06:17 am

5/22/2017 12:17 am

5/22/2017 12:17 am

5/16/2017 06:17 am

5/16/2017 06:17 am

5/16/2017 06:17 am

5/10/2017 06:17 am